Your search returned 195 studies. (Get alerts for new studies):
- Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Conditions: Cervical Cancer - Endometrial Cancer - Fallopian Tube Cancer - Hereditary Breast/Ovarian Cancer (brca1, brca2) - Ovarian Cancer - Sarcoma - Uterine Leiomyomata - Vaginal Cancer - Vulvar Cancer
1 Location available
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
248 Locations available
- Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors
Conditions: Brain and Central Nervous System Tumors - Extragonadal Germ Cell Tumor - Ovarian Cancer - Teratoma - Testicular Germ Cell Tumor
2 Locations available
- Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Conditions: Breast Cancer - Colorectal Cancer - Gastric Cancer - Liver Cancer - Melanoma (Skin) - Metastatic Cancer - Ovarian Cancer - Pancreatic Cancer
1 Location available
- Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Prima
Conditions: Brenner Tumor - Fallopian Tube Cancer - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated A
255 Locations available
- Spectroscopy With Surface Coils and Decoupling
Conditions: Adrenal Cortical Cancer - Brain Cancer - Breast Cancer - CNS Cancer - Colon Cancer - HEENT Cancer - Hodgkin's Disease - Kaposi's Sarcoma - Liver Cancer - Lung Cancer - Non-Hodgkin's Lymphoma - Ovarian Cancer - Pancreatic Cancer - Prostate Cancer - Rectal
1 Location available
- Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer
Conditions: Adenocarcinoma of the Ovary
3 Locations available
- Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age
Conditions: Breast Cancer - Hereditary Breast/Ovarian Cancer (brca1, brca2)
2 Locations available
- Dasatinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot be Removed by Surgery
Conditions: Breast Cancer - Gastrointestinal Stromal Tumor - Intraocular Melanoma - Kidney Cancer - Lung Cancer - Melanoma (Skin) - Ovarian Cancer - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
Conditions: Breast Cancer
6 Locations available
- Vorinostat, Carboplatin and Gemcitabine Plus Vorinostat Maintenance in Women With Recurrent, Platinum-Sensitive Epithelial Ovarian, Fallopian Tube, or
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
2 Locations available
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Conditions: Kidney Cancer - Head and Neck Cancer - Breast Cancer - Non-small Cell Lung Cancer - Colorectal Cancer - Pancreatic Cancer - Ovarian Cancer - Esophageal Cancer - Gliomas
1 Location available
- Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer
Conditions: Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer
Conditions: Ovarian Cancer
1 Location available
- Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Hereditary Breast/Ovarian Cancer - BRCA1 - Hereditary Breast/Ovarian Cancer - BRCA2 - Male Breast Cancer - Progesterone Receptor-negative Breast Cancer - Recurrent Breast Cancer - Stage IV Breast Cancer - Triple-
1 Location available
- Study of Individuals and Families at High Risk for Testicular Cancer
Conditions: Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Ovarian Cancer - Testicular Germ Cell Tumor
1 Location available
- Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors - Intraocular Melanoma - Lung Cancer - Melanoma (Skin) - Metastatic Cancer - Neuroblastoma - Ovarian Cancer - Retinoblastoma - Sarcoma - Small Intestine Cancer
1 Location available
- Stress, Immunity and Cervical Cancer: Biobehavioral Outcomes
Conditions: Ovarian Cancer
1 Location available
- A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- Cancer Screening and Prevention Program for High Risk Women
Conditions: Ovarian Cancer - Breast Cancer
3 Locations available
- Assessment of Screening Modalities for Gynecologic Cancers
Conditions: Ovarian Cancer - Endometrial Cancer
1 Location available
- Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
1 Location available
- Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer - Psychosocial Effects of Cancer and Its Treatment
118 Locations available
- Carboplatin, Paclitaxel, Bevacizumab, and ABT-888 in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
Conditions: Brenner Tumor - Ovarian Carcinosarcoma - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated
17 Locations available
- Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Rec
Conditions: Cognitive/Functional Effects - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
164 Locations available
- Irinotecan and Bevacizumab for Recurrent Ovarian Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Carcinoma
2 Locations available
- Cediranib and Olaparib in Combination for Recurrent Ovarian or Triple-Negative Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - HER2-negative Breast Cancer - Ovarian Endometrioid Adenocarcinoma - Ovarian Papillary Serous Carcinoma - Ovarian Serous Cystadenocarcinoma - Progesterone Receptor-negative Breast Cancer - Recurrent Breast Cancer
20 Locations available
- Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Conditions: Ovarian Cancer
58 Locations available
- Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors
Conditions: Adenocarcinoma of the Pancreas - Adenocarcinoma of the Stomach - BRCA1 Mutation Carrier - BRCA2 Mutation Carrier - Ovarian Mucinous Cystadenocarcinoma - Recurrent Breast Cancer - Recurrent Colon Cancer - Recurrent Gastric Cancer - Recurrent Ovarian Epithe
1 Location available
- Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Conditions: HIV Infection - Recurrent Anal Cancer - Recurrent Breast Cancer - Recurrent Esophageal Cancer - Recurrent Gastric Cancer - Recurrent Metastatic Squamous Neck Cancer With Occult Primary - Recurrent Non-small Cell Lung Cancer - Recurrent Ovarian Epithelial
2 Locations available
- Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
Conditions: Childhood Germ Cell Tumor - Ovarian Cancer - Teratoma
1 Location available
- Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
Conditions: Ovarian Cancer - Renal Cancer - Non-small Cell Lung Cancer - Small Cell Lung Cancer - Solid Tumors - Multiple Myeloma - Lymphoma
3 Locations available
- Intraperitoneal Paclitaxel, Doxorubicin, and Cisplatin in Treating Patients With Endometrial Cancer
Conditions: Endometrial Cancer - Ovarian Cancer
5 Locations available
- Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
Conditions: Breast Neoplasms - Ovarian Neoplasms - Colonic Neoplasms - Prostatic Neoplasms - Uterine Cervical Neoplasms - Leukemia - Lymphoma, Non-Hodgkin
1 Location available
- Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer
Conditions: Ovarian Cancer - Peritoneal Cancer - Fallopian Tube Cancer
1 Location available
- Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblasto
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Liver Cancer - Neuroblastoma - Ototoxicity - Ovarian Cancer - Sarcoma
68 Locations available
- Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer - Uterine Cancer - Vaginal Cancer - Vulvar Cancer
1 Location available
- A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tum
Conditions: Solid Tumors - Ovarian Cancer
8 Locations available
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Ovarian Mucinous Cystadenocarcinoma - Ovarian Mucinous Cystadenoma With Proliferating Activity - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Stage IA Fallopian Tube Cancer - Stage IA Ovarian Epithelial Cancer - Stage IB Fallopi
209 Locations available
- Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal C
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
10 Locations available
- Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy
Conditions: Melanoma - Ovarian Cancer - Sarcoma - Bone - CNS-Spinal CD/MEMBR, NOS - Lymph Nodes - Soft Tissue
1 Location available
- Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remis
Conditions: Fallopian Tubes - Ovarian Cancer - Peritoneal Cancer
1 Location available
- Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
Conditions: Advanced or Recurrent Solid Tumors - Breast Neoplasms - Ovarian Cancer, Epithelial - Ewing Sarcoma - Small Cell Lung Carcinoma - Prostate Cancer - Pancreas Cancer
5 Locations available
- VTX-2337 and Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal C
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
8 Locations available
- Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer
Conditions: Stage III Ovarian Epithelial Cancer - Stage III Ovarian Germ Cell Tumor - Stage IV Ovarian Epithelial Cancer - Stage IV Ovarian Germ Cell Tumor
1 Location available
- Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavit
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
181 Locations available
- Study of Individuals and Families at High Risk for Breast or Ovarian Cancer
Conditions: Breast Cancer - Hereditary Breast/Ovarian Cancer (brca1, brca2) - Ovarian Cancer
1 Location available
- Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epitheli
Conditions: Ovarian Cancer - Primary Peritoneal Cavity Cancer
1 Location available
- Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Conditions: Breast Cancer - Chronic Myeloproliferative Disorders - Gestational Trophoblastic Tumor - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Neuroblastoma - Ovarian C
1 Location available
- Ovarian Dendritic Cell Vaccine Trial
Conditions: Ovarian Cancer
1 Location available
- Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
Conditions: Adult Primary Hepatocellular Carcinoma - Advanced Adult Primary Liver Cancer - Endometrial Papillary Serous Carcinoma - Localized Unresectable Adult Primary Liver Cancer - Metastatic Gastrointestinal Carcinoid Tumor - Ovarian Carcinosarcoma - Ovarian Endo
47 Locations available
- MLN8237 in Patients With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breas
Conditions: Ovarian Carcinoma - Fallopian Tube Cancer - Peritoneal Cancer - Breast Carcinoma
2 Locations available
- Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemothera
Conditions: Epithelial Ovarian Cancer
1 Location available
- Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer - Breast Cancer
1 Location available
- Autologous OC-DC Vaccine in Ovarian Cancer
Conditions: Chemotherapy - Tumor - Ovarian Cancer
1 Location available
- Safety Study of MGAH22 in HER2-positive Carcinomas
Conditions: Breast Cancer - Gastric Cancer - Bladder Cancer - Ovarian Cancer - Non-small Cell Lung Cancer
1 Location available
- Phase II of Carbo/Pralatrexate in Rec. Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
2 Locations available
- A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers
Conditions: Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer, - Primary Peritoneal Cancer or Endometrial Cancer - Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer
3 Locations available
- Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer
Conditions: Healthy, no Evidence of Disease - Hereditary Breast/Ovarian Cancer - BRCA1 - Hereditary Breast/Ovarian Cancer - BRCA2
3 Locations available
- Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids
Conditions: Endometrial Cancer - Ovarian Cancer
1 Location available
- Carboplatin, Pegylated Liposomal Doxorubicin Hydrochloride, and Everolimus in Treating Patients With Relapsed Ovarian Epithelial, Fallopian Tube, or P
Conditions: Fallopian Tube Cancer - Peritoneal Cavity Cancer - Recurrent Ovarian Epithelial Cancer
1 Location available
- Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
Conditions: Advanced Solid Malignant Tumors - Advanced Ovarian Cancer
4 Locations available
- Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney
Conditions: Extensive Stage Small Cell Lung Cancer - Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor - Recurrent Breast Cancer - Recurrent Melanoma - Recurrent Non-small Cell Lung Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Ovarian Germ Cel
15 Locations available
- Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Conditions: Ovarian Cancer
37 Locations available
- Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- AZD2281 and Carboplatin in Treating Patients With BRCA1/BRCA2-Associated, Hereditary, or Triple Negative Metastatic or Unresectable Breast Cancer or O
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer - Hereditary Breast/Ovarian Cancer (brca1, brca2) - Ovarian Cancer
1 Location available
- OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
32 Locations available
- Veliparib in Treating Patients With Malignant Solid Tumors That Did Not Respond to Previous Therapy
Conditions: BRCA1 Mutation Carrier - BRCA2 Mutation Carrier - Estrogen Receptor-negative Breast Cancer - Fallopian Tube Cancer - HER2-negative Breast Cancer - Hereditary Breast/Ovarian Cancer (BRCA1, BRCA2) - Male Breast Cancer - Primary Peritoneal Cavity Cancer - Pr
7 Locations available
- Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Ovarian Cancer
1 Location available
- Pemetrexed and Carboplatin in Recurrent Platinum Sensitive Ovarian Cancer
Conditions: Ovarian Cancer - Peritoneal Cancer - Fallopian Tube Cancer
1 Location available
- M. D. Anderson Symptom Inventory - Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- AMG 102 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
30 Locations available
- Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Prim
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Recurren
8 Locations available
- Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, Peritoneal Cancer, or Recurrent T
Conditions: Breast Cancer - Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
22 Locations available
- Neoadjuvant Therapy for Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer
3 Locations available
- Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary P
Conditions: Brenner Tumor - Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Mucinous Cystadenocarcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Stage II
25 Locations available
- SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cis
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
4 Locations available
- Olaparib in Combination With Carboplatin for Refractory or Recurrent Women's Cancers
Conditions: Mixed Muellerian Cancer - Cervical Cancer - Ovarian Cancer - Breast Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer - Endometrial Cancer - Carcinosarcoma
1 Location available
- DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Conditions: Pleuropulmonary Blastoma - Cystic Nephroma - Ovarian Sertoli-Leydig Cell Tumors - Ocular Medulloepithelioma - Nasal Chondromesenchymal Hamartoma
1 Location available
- Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplan
Conditions: Chronic Myeloproliferative Disorders - Kidney Cancer - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Neuroblastoma - Oral Complications - Ovarian Cancer - Pain
1 Location available
- Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Na
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Head and Neck Cancer - Lymphoma - Nausea and Vomiting - Neuroblastoma - Ovarian Cancer - Sarcoma
1 Location available
- Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Perito
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors
Conditions: Bladder Cancer - Brain and Central Nervous System Tumors - Breast Cancer - Esophageal Cancer - Extragonadal Germ Cell Tumor - Gastric Cancer - Lung Cancer - Ovarian Cancer - Prostate Cancer
1 Location available
- Data Collection for Patients With Low Grade Ovarian Carcinoma
Conditions: Ovarian Cancer - Peritoneum Tumors
1 Location available
- Comparing Three Combination Chemotherapy Regimens in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Pr
Conditions: Fallopian Tube Cancer - Metastatic Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
3 Locations available
- Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian S
Conditions: Ovarian Cancer
54 Locations available
- Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
Conditions: Pleural Metastases - Breast Cancer - Colon Cancer - Ovarian Cancer - Uterine Cancer - Renal Cell Cancer - Thymic Cancer
1 Location available
- Predictors of Ovarian Insufficiency in Young Breast Cancer Patients
Conditions: Breast Cancer - Ovarian Insufficiency - Ovarian Failure
2 Locations available
- Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and P
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
1 Location available
- Panitumumab and Gemcitabine in Relapsed Ovarian Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- Ovarian Reserve Testing in Female Young Adult Cancer Survivors
Conditions: Cancer - Infertility
1 Location available
- AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer
Conditions: Breast Cancer - Ovarian Cancer
1 Location available
- EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer,
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
3 Locations available
- TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer
95 Locations available
- Cyclophosphamide and Vaccine Therapy in Treating Patients With Stage II-III Breast, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Recurrent Breast Cancer - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Ovarian Germ Cell Tumor - Recurrent Primary Peritoneal Cavity Cancer - Stage IIA Ovarian Epithelial Cancer - Stage IIA Ovarian Germ Cell Tumor - St
1 Location available
- Study of 124I-NM404 in Advanced Solid Malignancies
Conditions: Triple Negative Breast, Prostate, Colorectal, Gastric, Ovarian, Pancreatic, Esophageal, Soft Tissue Sarcoma, and Head & Neck Cancer
1 Location available
- Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer
Conditions: Ovarian Cancer - Peritoneal Cancer - Fallopian Tube Cancer
3 Locations available
- Beta-Blocker / Ovarian
Conditions: Ovarian Cancer - Primary Peritoneal Carcinoma - Fallopian Tube Cancer
1 Location available
- Salvage Ovarian FANG Vaccine + Bevacizumab
Conditions: Stage IIIC Ovarian Cancer
1 Location available
- Interactive Educational Website for Women With Ovarian Cancer & Caregivers
Conditions: Stage III Ovarian Cancer - Stage IV Ovarian Cancer - Recurrent Ovarian Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer
1 Location available
- Ph I Dose Escalation Study of Antibody-drug Conjugate IMMU-132 in Patients With Advanced Epithelial Cancers
Conditions: Advanced Epithelial Cancers - Ovarian Cancer - Prostate Cancer - Lung Cancer - Breast Cancer - Gastric Cancer - Colorectal Cancer - Pancreatic Cancer - Hepatocellular Cancer
3 Locations available
- Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
Conditions: Leydig Cell Tumor - Ovarian Sarcoma - Ovarian Stromal Cancer - Pseudomyxoma Peritonei - Recurrent Cervical Cancer - Recurrent Endometrial Carcinoma - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Ovarian Germ Cell Tumor
1 Location available
- A Study of LY2228820 for Recurrent Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
15 Locations available
- Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum Sensitive Ovarian Cancer Patients
Conditions: Ovarian Cancer
10 Locations available
- A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer
Conditions: Ovarian Cancer - Malignant Female Reproductive System Neoplasm - Cancer - Ovarian Tumor - Ovarian Epithelial Cancer Recurrent
2 Locations available
- Investigating the Impact of Tamoxifen Therapy on Ovarian Aging
Conditions: Breast Cancer - Fertility
1 Location available
- Doxorubicin + BIBF 1120 in Patients for Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- BNC105P Combination Study in Partially Platinum Sensitive Ovarian Cancer Patients
Conditions: Ovarian Cancer
2 Locations available
- CRLX101 for Recurrent Ovarian/Tubal/Peritoneal Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
4 Locations available
- Phase I of BKM120/Olaparib for Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer
Conditions: Ovarian Cancer - Breast Cancer
1 Location available
- Phase II Trial of Dalantercept to Treat Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Carcinoma
21 Locations available
- 18F-CP18 Imaging Studies for Cancer Treatment With Birinapant
Conditions: Ovarian Neoplasms - Ovarian Cancer - Fallopian Tube Neoplasms - Fallopian Tube Cancer
1 Location available
- Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Comb
Conditions: Ovarian Cancer - Fallopian Tubes Cancer - Peritoneal Cancer
6 Locations available
- BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
1 Location available
- Psychosexual Intervention in Patients With Stage I-III Gynecologic Cancer
Conditions: Leydig Cell Tumor - Ovarian Sarcoma - Ovarian Stromal Cancer - Stage I Gestational Trophoblastic Tumor - Stage I Uterine Sarcoma - Stage I Vaginal Cancer - Stage I Vulvar Cancer - Stage IA Cervical Cancer - Stage IA Endometrial Carcinoma - Stage IA Fallop
1 Location available
- Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
18 Locations available
- Analysis of Tumors From Patients With Inherited Cancers Having Had Two Surgeries (Primary + Recurrent, or 2 Separate Types of Cancer)
Conditions: Breast Cancer - Ovarian Cancer
1 Location available
- Changes in Performance Status and Symptom Distress in Older Patients With Advanced Ovarian Epithelial Cancer Undergoing Surgery and/or Chemotherapy
Conditions: Ovarian Cancer
1 Location available
- Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Can
Conditions: Ovarian Clear Cell Cystadenocarcinoma - Stage III Ovarian Epithelial Cancer - Stage IV Ovarian Epithelial Cancer
108 Locations available
- The Effect of Guided Imagery and Music Therapy on Post-Operative Recovery After Gynecological Oncology Surgery
Conditions: Ovarian Cancer - Uterine Cancer
1 Location available
- Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
8 Locations available
- Bevacizumab With or Without Fosbretabulin Tromethamine in Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavi
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
27 Locations available
- Safety Study of MGA271 in Refractory Cancer
Conditions: Prostate Cancer - Pancreatic Cancer - Melanoma - Renal Cell Carcinoma - Ovarian Cancer - Colorectal Cancer - Gastric Cancer - Bladder Cancer - Non-small Cell Lung Cancer - Glioblastoma
3 Locations available
- Veliparib, Doxorubicin Hydrochloride, and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube
Conditions: Ovarian Clear Cell Cystadenocarcinoma - Ovarian Endometrioid Adenocarcinoma - Ovarian Mixed Epithelial Carcinoma - Ovarian Serous Cystadenocarcinoma - Ovarian Undifferentiated Adenocarcinoma - Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial
8 Locations available
- Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
131 Locations available
- A Study of DMOT4039A in Patients With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer
Conditions: Ovarian Cancer, Pancreatic Cancer
4 Locations available
- Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy
Conditions: Epithelial Ovarian Cancer
14 Locations available
- Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer
1 Location available
- First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMGN853 in Adults With Ovarian Cancer and Other FO
Conditions: FOLR-1 Postive Solid Tumors
4 Locations available
- A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
1 Location available
- A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
3 Locations available
- A Phase 2 Study of the IDO Inhibitor INCB024360 Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remis
Conditions: Biochemical-recurrent Only Epithelial Ovarian Cancer - Primary Peritoneal Carcinoma - Fallopian Tube Cancer
11 Locations available
- Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer
1 Location available
- Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
Conditions: Anxiety Disorder - Fallopian Tube Cancer - Fatigue - Nausea and Vomiting - Neurotoxicity - Ovarian Cancer - Primary Peritoneal Cavity Cancer
111 Locations available
- Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Carcinoma
1 Location available
- A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor
Conditions: Metastatic Solid Tumor - Breast Cancer - Ovarian Cancer
4 Locations available
- A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
Conditions: Ovarian Neoplasms
2 Locations available
- Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer
Conditions: Epithelial Ovarian Cancer - Peritoneal Neoplasms - Fallopian Tube Neoplasms
1 Location available
- Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer - Stage IV Fallopian Tube Cancer - Stage IV Ovarian Epithelial Cancer - Stage IV Primary Peritoneal Cavity Cancer
2 Locations available
- Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer
Conditions: Ovarian Cancer
3 Locations available
- Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients
Conditions: Invasive Epithelial Ovarian Cancer - Primary Peritoneal Carcinoma - Fallopian Tube Cancer
1 Location available
- Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Canc
Conditions: Ovarian Cancer, Pancreatic Cancer
4 Locations available
- Amatuximab for High Mesothelin Cancers
Conditions: Carcinoma, Pancreatic Ductal - Mesothelioma - Ovarian Neoplasms - Carcinoma, Non-Small-Cell Lung
1 Location available
- Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer
Conditions: Recurrent Ovarian Epithelial Cancer - Recurrent Ovarian Germ Cell Tumor - Malignant Tumor of Peritoneum - Stage IV Ovarian Epithelial Cancer - Stage IV Ovarian Germ Cell Tumor
1 Location available
- Cryopreservation of Ovarian Tissue
Conditions: Cancer - Risk of Premature Ovarian Failure - Fertility Preservation
1 Location available
- Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer
Conditions: Stage III Ovarian Cancer - Stage IV Ovarian Cancer - Uterine Cancer
1 Location available
- SGI-110 in Combination With Carboplatin in Ovarian Cancer
Conditions: Ovarian Cancer
7 Locations available
- Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
Conditions: Anxiety Disorder - Depression - Fatigue - Leydig Cell Tumor - Ovarian Sarcoma - Ovarian Stromal Cancer - Pain - Peritoneal Carcinomatosis - Pseudomyxoma Peritonei - Recurrent Breast Cancer - Recurrent Cervical Cancer - Recurrent Endometrial Carcinoma - Re
1 Location available
- Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel
Conditions: Breast Cancer - Ovarian Neoplasm - Pain
1 Location available
- Analyzing the Composition of Tears to Identify Cancer
Conditions: Breast Cancer - Ovarian Cancer - Colon Cancer - Benign Disease
1 Location available
- Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epi
Conditions: Cognitive/Functional Effects - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer - Weight Changes
132 Locations available
- Exhaled Breath Biomarkers in Finding Ovarian Epithelial Cancer in Patients With Newly Diagnosed Ovarian Epithelial Cancer, Polycystic Ovarian Syndrome
Conditions: Ovarian Cancer
4 Locations available
- Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer
Conditions: Tumor - Ovarian Cancer
11 Locations available
- Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Conditions: Ovarian Cancer - Peritoneal Cavity Cancer - Unspecified Adult Solid Tumor, Protocol Specific
2 Locations available
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
101 Locations available
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
359 Locations available
- First-line Treatment of Weekly Paclitaxel With Carboplatin and Bevacizumab in Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer
1 Location available
- N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer
Conditions: Ovarian Carcinoma, Stage 3 or 4 - Epithelial Ovarian Carcinoma - Primary Peritoneal Carcinoma
1 Location available
- TRINOVA-2: Trebananib in Ovarian Cancer-2
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cancer
8 Locations available
- Trial of Adjuvant FANG™ Vaccine for High Risk Stage III/IV Ovarian Cancer
Conditions: Ovarian Cancer
2 Locations available
- A Study of MK-1775 in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ova
Conditions: Ovarian Cancer
7 Locations available
- Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Patients With Non-Small Cell Lung Cancer and Platinum Resistant Ovarian Cancer
Conditions: Non-Small Cell Lung Cancer, Ovarian Cancer
3 Locations available
- Patient Reported Symptoms in Ovarian Cancer (PRECISION)
Conditions: Ovarian Cancer
21 Locations available
- A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
10 Locations available
- EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer
Conditions: Ovarian Cancer Recurrent
14 Locations available
- Memory and Thinking Skills Workshop in Improving Cognitive Rehabilitation in Ovarian Cancer Survivors
Conditions: Cancer Survivor - Cognitive/Functional Effects - Ovarian Neoplasm
1 Location available
- Accelerating Gastrointestinal Recovery
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- A Novel Method of Screening for Ovarian Cancer Using Gynecologic Fluids and Mucus
Conditions: Ovarian Cancer
1 Location available
- Stress Reduction in Ovarian Cancer
Conditions: Ovarian, Fallopian, and Primary Peritoneal Cancer
1 Location available
- Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- Early Detection of Ovarian Cancer
Conditions: Ovarian Cancer
5 Locations available
- Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants
Conditions: Ovarian Cancer
1 Location available
- Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
23 Locations available
- Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Conditions: Breast Cancer - Ovarian Cancer - Gynecologic Cancers - Ovarian/Peritoneal/Fallopian Cancer
1 Location available
- A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women
Conditions: Epithelial Ovarian Cancer
5 Locations available
- Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Conditions: Fallopian Tube Neoplasms - Ovarian Cancer - Primary Peritoneal
1 Location available
- Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Lung Cancer - Ovarian Cancer - Prostate Cancer
1 Location available
- Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive
Conditions: Endometrial Cancer - Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer - Gastrointestinal Carcinoma - Pancreatic Carcinoma - Lung Cancer - Esophageal Carcinoma
1 Location available
- Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases - Ovarian Neoplasms
1 Location available
- Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer
Conditions: Ovarian Carcinoma - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- Vaccine Therapy in Treating Patients With Metastatic Solid Tumors
Conditions: Malignant Solid Tumour - Breast Cancer - Malignant Tumor of Colon - GIST - Ovarian Cancer
1 Location available
- Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin
Conditions: Infertility - Breast Cancer
1 Location available
- Juice Plus+ and Juice Plus+ Complete in Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study
Conditions: Ovarian Cancer
1 Location available
- Evaluation of Metformin, Targeting Cancer Stem Cells for Prevention of Relapse in GYN Patients
Conditions: Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
1 Location available
- Phase Ib Trial of Folate Binding Protein Vaccine in Ovarian Cancer
Conditions: Ovarian Cancer - Endometrial Cancer
2 Locations available
- Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Conditions: Recurrent Fallopian Tube Cancer - Recurrent Ovarian Epithelial Cancer - Recurrent Primary Peritoneal Cavity Cancer - Stage IIA Fallopian Tube Cancer - Stage IIA Ovarian Epithelial Cancer - Stage IIA Primary Peritoneal Cavity Cancer - Stage IIB Fallopian T
1 Location available
- VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal C
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
51 Locations available
- Study Of Intraperitoneal EGEN-001 Administered In Combination With Pegylated Liposomal-Doxorubicin In Patients With Recurrent Or Persistent Epithelial
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Carcinoma
2 Locations available
- The Effects Of Yoga On Quality Of Life Among A Population Of Ovarian/ Fallopian Tube/ Primary Peritoneal Cancer Patients Receiving Chemotherapy: A Fea
Conditions: Ovarian Cancer
1 Location available
|